AxoGen (AXGN) Tops Q3 EPS by 5c

AxoGen (NASDAQ: AXGN) reported Q3 EPS of $0.12, $0.05 better than the analyst estimate of $0.07. Revenue for the quarter came in at $60.1 million versus the consensus estimate of $56.94 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Edgewell stock surges on report of rejected takeover bid
• Avis Budget Group reaches $650M settlement with Pentwater Capital